Plasmid DNA Manufacturing Market Set for Rapid Growth During 2022-2027

The global biopharmaceutical industry has seen a growth in the plasmid DNA manufacturing business. The rising use of plasmid DNA in the biopharmaceutical industry for producing vaccines and treatments for a variety of ailments is driving up demand for plasmid DNA. Overall, the plasmid DNA manufacturing market is likely to grow at a promising CAGR of 17.2% in the long run to reach US$ 1.5 Billion in 2027.